Financial Investment Company (SIF) Oltenia will launch a stock purchase offer for drugmaker Sicomed Bucharest today. Surprisingly, the value of the offer amounts to only 190m ROL (a little over 4,000 euros), setting a price of 3,800 ROL per share, slightly more than the Stock Exchange price. The stake accounts for 0.012% in Sicomed. The financial investment company controls 9.99% in Sicomed and needs to launch a public offer to exceed the 10% limit. If the offer is successful, SIF Oltenia will be able to buy Sicomed shares from the market up to a 33% stake. ZF